Skip to content

A clinical trial to study effectiveness of low dose steroid in nephrotic syndrome.

Efficacy of low dose prednisolone in children with steroid sensitive nephrotic syndrome - An open labelled randomized pilot trial - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083231
Enrollment
36
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

Intervention1: Low dose steroid: Patient in intervention group will receive low dose (1.5 mg/kg/day) prednisolone till remission followed by 1.5mg/kg alternate day for two weeks and 1mg/kg alternate d

Sponsors

Aiims Bathinda
Lead Sponsor
Aiims Bathinda
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Children aged between 2 to 13 years present to pediatric OPD or IPD with steroid sensitive nephrotic syndrome. 2)Those in relapse 3)Those patients who were not receiving prednisone at the time of relapse and had never before received other steroid sparing drugs.

Exclusion criteria

Exclusion criteria: 1)Steroid resistant and steroid dependent 2)Patient with nephrotic syndrome due to secondary causes. 3)Patients with frequent relapses 4)Patients in whom initial episode was not treated with at least 2 mg/kg of daily steroids for 4 weeks followed by 4 weeks of 1.5 mg/kg alternate day steroids during.

Design outcomes

Primary

MeasureTime frame
Rate of relapses in steroid sensitive nephrotic syndrome on low dose prednisoloneTimepoint: 1 year

Secondary

MeasureTime frame
1)Comparison of steroid toxicity in both the groups. 2)Difference in Linear growth with both the regimen Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Raksha Ranjan

AIIMS Bathinda

raksharanjan19@gmail.com9952737293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026